CVE-2020-10627 Missing authorization in Omnipod Insulin Management System
Attackers can intercept data and modify insulin pump settings due to missing authentication in the RF protocol, posing severe health risks.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2020-10627?
CVE-2020-10627 is a high-severity missing authorization vulnerability in Insulet Omnipod Insulin Management System, published on 1 Dec 2021. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Weakness: CWE-284
Which versions are affected by CVE-2020-10627?
It affects 1 product.
Products include Insulet Omnipod Insulin Management System Firmware.
How do I fix CVE-2020-10627?
No fix has been published for CVE-2020-10627 yet. Limit exposure of the affected software until one is available.
Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.
Is CVE-2020-10627 being exploited?
There is no known exploitation of CVE-2020-10627 in the wild and no public exploit code.
Sources
Also known as GHSA-r26f-v6j2-2h4j.